Raytheon's $20.7B AMRAAM Pact as 2025 Output Nearly Doubles

For space and defense planners, the AMRAAM contract is a case study in how multiyear procurement authority can underwrite the industrial base for high-end guided munitions. With allied air forces integrated through the Foreign Military Sales programme and production nearly doubling from 2024 to 2025, the deal's real significance may be its use as a template for other long-range weapons lines.

The US Department of War's award of an up to $20.7 billion AMRAAM production contract to Raytheon—an RTX business—represents a decisive move to convert missile production from episodic annual purchases into a long-term industrial commitment. Awarded on September 25, 2026 and announced three days later, the five-year agreement includes options for two additional years and consolidates demand from the US Air Force, US Navy, and allied customers purchasing through the Foreign Military Sales programme. The $20.7 billion figure is explicitly a maximum stated value, not an amount already obligated, but the award's structure and multiyear procurement authority provide a degree of production certainty that defense manufacturers have long sought.

“

Financially, if the full $20.7 billion ceiling were realized across the five-year base period and two option years, it would imply roughly $3 billion per year in AMRAAM production value for Raytheon and its supply base.

The Advanced Medium-Range Air-to-Air Missile, or AMRAAM, is a beyond-visual-range weapon carried by numerous Western fighter fleets, making it a foundational element of allied air superiority. By folding Air Force, Navy, and Foreign Military Sales demand into one long-term contract, the Department of War is signaling that it wants to move beyond stop-start annual buying cycles, which have historically discouraged suppliers from investing in tooling, materials, and skilled labor. Michael P. Duffey, under secretary of war for acquisition and sustainment, framed the award as part of an effort to 'build the Arsenal of Freedom,' joining the contract to a broader industrial policy emphasis on expanding domestic weapons manufacturing.

The production data disclosed, while deliberately limited, points to an accelerating ramp. The Department said AMRAAM production had nearly doubled compared with previous levels, and RTX said production in 2025 was nearly twice that of 2024. Neither announcement disclosed actual unit counts, however, leaving the true baseline and the scale of the increase opaque. A separate earlier agreement supported annual production of at least 1,900 AMRAAMs, a production goal cited by Raytheon but not tied to the value of the new award. The company also did not specify how many missiles would be delivered under this contract or provide a delivery timetable. This creates a tension between the impressive top-line ceiling and the absence of unit-level detail: the award guarantees a financial envelope, but not necessarily a specific number of missiles.

Financially, if the full $20.7 billion ceiling were realized across the five-year base period and two option years, it would imply roughly $3 billion per year in AMRAAM production value for Raytheon and its supply base. That is a meaningful long-term demand signal for RTX investors and for the sub-tier manufacturers that supply propulsion, guidance sections, warheads, and airframe components. It also reduces the boom-bust risk that has plagued munitions lines after conflicts wind down. The Department thanked Congress for providing multiyear procurement authority for AMRAAM, and explicitly said further authority and funding would help sustain production and give manufacturers greater certainty. That statement is effectively a request for continued legislative support, and it suggests the long-term health of the AMRAAM line is not yet fully funded.